Cebidiofen and polyoxyfen (more details) both patent-pending product formulations (for pharmaceutical foods recently acquired by Health Advance, Inc.; OTC: HADV.) , which contain ibuprofen (as its active ingredient) and contain botanical extract blends with cannabidiol ("CBD") and Mitragyna speciosa ("kratom")Health Advance, Inc. (OTC: HDV), a micro-cap company that announced its plans on development of the first FDA regulated pharmaceutical (made from ibuprofen and botanical extract blends derived from cannabidiol [CBD], kava and krato) over the next two onths with the support of a research organization that has been responsible for assisting the clinical studies and product testing for medical foods and pre-approved durgs that are in phase three - briefly saying that be first CBD and kratom derived from organic drugs for pain, drug/alcohol withdrawal, and other severe illness is only months away from the Healthcare Marketplace.
Health Advance, Inc. (OTC: HADV) Brief Company Overview
Find out market research survey and details on Health Advance, Inc. (OTC: HADV) at www.painmedsurvey.org. or contact us at 888 (888)429-6535.Recent News: [YAHOO NEWS] Green Health Advocates: Has America Gone Kratom? CBD is Cool But Maybe More Trendy Competitors Exist.
Disclaimer: information are derived from other sites, credits to the respective owners.
